
Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
                                    Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
会议期间发布的数据显示出安斯泰来在各种难治性实体瘤和血液恶性肿瘤领域尚未满足需求方面的研究进展 2023年5月26日,东京 -...
安斯泰来的存在意义是“通过提供创新和可靠的药品,为改善全球人类的健康做贡献”。为了实现这一目标,我们致力于营造一个包容的工作环境,
*本文来源于近日《人民日报》健康客户端刊发的文章,节选如下:...
*近日,《医药经济报》刊发安斯泰来沈阳工厂总经理原田芳行先生的署名文章,全文如下:...
数据显示,研究药物zolbetuximab联合CAPOX与对照组单独使用CAPOX相比,疾病进展或死亡风险降低了31.3% 研究对Claudin...
Read more about 安斯泰来在三月份的美国临床肿瘤学会(ASCO)全体大会系列会议上宣布Zolbetuximab的GLOW III期临床研究积极成果
